- 专利标题： COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
-
申请号： US17901775申请日： 2022-09-01
-
公开(公告)号： US20230060334A1公开(公告)日： 2023-03-02
- 发明人: Christopher G. Nasveschuk , Rhamy Zeid , Ning Yin , Katrina L. Jackson , Gesine Kerstin Veits , Moses Moustakim , Jeremy L. Yap
- 申请人： C4 Therapeutics, Inc.
- 申请人地址： US MA Watertown
- 专利权人： C4 Therapeutics, Inc.
- 当前专利权人： C4 Therapeutics, Inc.
- 当前专利权人地址： US MA Watertown
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61P35/00 ; C07D401/14
摘要：
BRD9 protein degradation compounds or pharmaceutically acceptable salts thereof are provided for the treatment of disorders mediated by BRD9, including but not limited to abnormal cellular proliferation.
公开/授权文献
- US12049464B2 Compounds for targeted degradation of BRD9 公开/授权日：2024-07-30
信息查询
